In Vitro Stability of Fortified Ophthalmic Antibiotics Stored at-20°C for 6 Months

被引:12
作者
Chedru-Legros, Valerie [2 ]
Fines-Guyon, Marguerite [3 ]
Cherel, Aurelie [2 ]
Perdriel, Agathe [2 ]
Albessard, Francoise [4 ]
Debruyne, Daniele [4 ]
Mouriaux, Frederic [1 ]
机构
[1] Univ Hosp Caen, Dept Ophthalmol, F-14032 Caen, France
[2] Univ Hosp Caen, Dept Pharm, F-14032 Caen, France
[3] Univ Hosp Caen, Dept Microbiol, F-14032 Caen, France
[4] Univ Hosp Caen, Dept Pharmacol, F-14032 Caen, France
关键词
cornea; keratitis; antibiotics; drug stability; freezing; BACTERIAL KERATITIS; EYE DROPS; CEFTAZIDIME; VANCOMYCIN;
D O I
10.1097/ICO.0b013e3181c32573
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: This study evaluates the in vitro stability and sterility of fortified ophthalmic antibiotic preparations of 5% solutions (50 mg/mL) made from commercially available powders of amikacin, ceftazidime, and vancomycin stored at -20 degrees C for 6 months. Methods: Antibiotic solutions were prepared with aseptic techniques by reconstitution and dilution of the commercially available powders (amikacin, ceftazidime, and vancomycin) and stored at -20 degrees C. After various durations of storage, the stability of various physical and chemical properties was determined by a pH meter, an osmometer, and high-performance liquid chromatography. Microbiological activity was assayed according to the European Pharmacopoeia. Results: Solutions of 5% amikacin or ceftazidime in 0.9% sodium chloride and vancomycin in 5% dextrose were found to be physically, chemically, and microbiologically stable after storage at -20 degrees C for 190 days. A time limitation of 6 months is proposed. Conclusion: Fortified ophthalmic antibiotic solutions prepared and supplied by a pharmacy can be stored in freezers at -20 degrees C for later use.
引用
收藏
页码:807 / 811
页数:5
相关论文
共 21 条
[1]  
Arici MK, 1999, AUST NZ J OPHTHALMOL, V27, P426
[2]  
Barbault S., 1999, Journal de Pharmacie Clinique, V18, P183
[3]   Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases [J].
Bourcier, T ;
Thomas, F ;
Borderie, V ;
Chaumeil, C ;
Laroche, L .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (07) :834-838
[4]  
BOURCIER T, 2004, CORNEAL INFECT DIAGN, P39
[5]  
CHARLTON JF, 1992, INVEST OPHTH VIS SCI, V33, P937
[6]   Fortified antibiotic (vancomycin, amikacin and ceftazidime) eye drop stability assessment at-20 °C [J].
Chedru-Legros, V. ;
Fines-Guyon, M. ;
Cherel, A. ;
Perdriel, A. ;
Albessard, F. ;
Debruyne, D. ;
Mouriaux, F. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (08) :807-813
[7]   Prescribing fortified eye drops [J].
Chiquet, C. ;
Romanet, J.-P. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (04) :423-430
[8]  
*COUNC EUR, 2005, EUR PHARM, V1, P153
[9]  
ING H, 2003, PHARM HOSP, V38, P155
[10]  
Lin Chang-Ping, 1999, Kaohsiung Journal of Medical Sciences, V15, P80